Indoco Remedies Ltd (INDOCO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 601817,
    "name": "Indoco Remedies",
    "stock_name": "Indoco Remedies",
    "full_name": "Indoco Remedies Ltd",
    "name_url": "stocks-analysis/indoco-remedies",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "219.55",
    "chg": 2.55,
    "chgp": "1.18%",
    "dir": 1,
    "prev_price": "217.00",
    "mcapval": "2,025.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532612,
    "symbol": "INDOCO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE873D01024",
    "curr_date": "Jul 31, 03:30 PM",
    "curr_time": "15:39 PM",
    "last_traded_at": "Jul 31, 03:30 PM IST",
    "bse_nse_vol": "1.27 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indoco-remedies-601817-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indoco Remedies Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-upgraded-to-sell-on-technical-improvement-despite-weak-fundamentals-4128022",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndocoRemediesL_mojoScore_4128022.png",
        "date": "2026-07-30 08:05:00",
        "description": "Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 29 July 2026. This change is primarily driven by a shift in technical indicators, despite ongoing challenges in financial performance and valuation metrics. The company’s stock currently trades at ₹225.15, down 1.29% on the day, reflecting mixed signals for investors navigating a complex market environment."
      },
      {
        "title": "Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-technical-momentum-shifts-amid-mixed-market-signals-4127864",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndocoRemediesL_technicaldot_4127864.png",
        "date": "2026-07-30 08:01:27",
        "description": "Indoco Remedies Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend as of late July 2026. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the evolving price momentum, key technical indicators, and comparative market performance to provide investors with a comprehensive view of the stock’s current standing."
      },
      {
        "title": "Golden Cross Forms in Indoco Remedies Ltd — On a Day the Stock Fell 1.29%. What the Mixed Signals Mean",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-forms-golden-cross-indicating-potential-bullish-breakout-4126566",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndocoRemediesL_goldencross_4126566.png",
        "date": "2026-07-29 18:20:26",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Indoco Remedies Ltd, signalling a golden cross on 29 Jul 2026. Yet, the stock declined 1.29% on the same day, while monthly technical indicators remain bearish. This juxtaposition of signals calls for a detailed examination of the underlying data to assess the reliability of this technical event."
      },
      {
        "title": "Indoco Remedies Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-faces-technical-momentum-shift-amid-bearish-signals-4125063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndocoRemediesL_technicaldot_4125063.png",
        "date": "2026-07-29 08:02:06",
        "description": "Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from sideways movement to a mildly bearish trend. Despite some bullish weekly indicators, the overall technical landscape suggests caution for investors as the stock grapples with downward pressure and underperformance relative to broader market benchmarks."
      },
      {
        "title": "Indoco Remedies Q1 FY27: Sharp Turnaround Masks Deeper Structural Challenges",
        "link": "https://www.marketsmojo.com/news/result-analysis/indoco-remedies-q1-fy27-sharp-turnaround-masks-deeper-structural-challenges-4124594",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndocoRemedies_quaterlyResult_4124594.png",
        "date": "2026-07-28 17:46:04",
        "description": "Indoco Remedies Ltd. delivered a dramatic return to profitability in Q1 FY27 with a consolidated net profit of ₹64.99 crores, marking a stunning reversal from four consecutive quarters of losses. However, the stock plunged 7.93% following the results announcement, reflecting investor scepticism about the sustainability of this turnaround amidst mounting debt pressures and deteriorating operational efficiency. Trading at ₹228.10 with a market capitalisation of ₹2,272 crores, the Mumbai-based pharmaceutical company faces critical questions about whether this quarter represents a genuine inflection point or merely a temporary respite in an otherwise challenging trajectory."
      },
      {
        "title": "Indoco Remedies Ltd Hits Intraday Low Amid Price Pressure on 28 Jul 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-hits-intraday-low-amid-price-pressure-on-28-jul-2026-4124448",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndocoRemediesL_priceRelatedfactors_4124448.png",
        "date": "2026-07-28 13:46:51",
        "description": "Indoco Remedies Ltd experienced a notable decline today, touching an intraday low of Rs 234.30, reflecting significant price pressure amid a volatile trading session. The stock underperformed its sector and broader market indices, reversing gains from the previous three days."
      },
      {
        "title": "Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-technical-momentum-shifts-amid-mixed-market-signals-4121824",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndocoRemediesL_technicaldot_4121824.png",
        "date": "2026-07-27 08:01:45",
        "description": "Indoco Remedies Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day gain of 1.87%, the stock’s broader technical landscape remains mixed, with some weekly indicators showing strength while monthly signals suggest caution. This nuanced technical picture warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-4120166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndocoRemediesL_mojoScore_4120166.png",
        "date": "2026-07-25 10:10:28",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 July 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 25 July 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Indoco Remedies Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-faces-technical-momentum-shift-amid-bearish-signals-4116982",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndocoRemediesL_technicaldot_4116982.png",
        "date": "2026-07-23 08:02:22",
        "description": "Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish stance. This development comes amid mixed technical indicator readings and a significant drop in the stock price, raising concerns for investors amid a challenging market environment."
      }
    ],
    "total": 600,
    "sid": "601817",
    "stock_news_url": "https://www.marketsmojo.com/news/indoco-remedies-601817"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Jul-2026",
      "details": "Publication of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "28-Jul-2026",
      "details": "Audio recording of Earnings Conference Call on Unaudited Standalone & Consolidated Financial Results for the quarter ended 30-06-2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "28-Jul-2026",
      "details": "The Board of Directors in its Meeting held today i.e. 28th July 2026 has considered and approved 1. Re-appointment of Ms. Aditi Panandikar as the Managing Director of the Company for the period of 5 years commencing from 15th February 2027 to 14th February 2032 subject to the approval of the shareholders in the ensuing AGM. 2. Appointment of Mr. Sudhir Kadam as Senior Management Personnel designated as Sr. Vice President (Human Capital) of the Company w.e.f. 28th July 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indoco Remedies Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals

2026-07-30 08:05:00

Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 29 July 2026. This change is primarily driven by a shift in technical indicators, despite ongoing challenges in financial performance and valuation metrics. The company’s stock currently trades at ₹225.15, down 1.29% on the day, reflecting mixed signals for investors navigating a complex market environment.

Read full news article

Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-30 08:01:27

Indoco Remedies Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend as of late July 2026. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the evolving price momentum, key technical indicators, and comparative market performance to provide investors with a comprehensive view of the stock’s current standing.

Read full news article

Golden Cross Forms in Indoco Remedies Ltd — On a Day the Stock Fell 1.29%. What the Mixed Signals Mean

2026-07-29 18:20:26

The 50-day moving average has crossed above the 200-day moving average for Indoco Remedies Ltd, signalling a golden cross on 29 Jul 2026. Yet, the stock declined 1.29% on the same day, while monthly technical indicators remain bearish. This juxtaposition of signals calls for a detailed examination of the underlying data to assess the reliability of this technical event.

Read full news article

Indoco Remedies Ltd Faces Technical Momentum Shift Amid Bearish Signals

2026-07-29 08:02:06

Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from sideways movement to a mildly bearish trend. Despite some bullish weekly indicators, the overall technical landscape suggests caution for investors as the stock grapples with downward pressure and underperformance relative to broader market benchmarks.

Read full news article

Indoco Remedies Q1 FY27: Sharp Turnaround Masks Deeper Structural Challenges

2026-07-28 17:46:04

Indoco Remedies Ltd. delivered a dramatic return to profitability in Q1 FY27 with a consolidated net profit of ₹64.99 crores, marking a stunning reversal from four consecutive quarters of losses. However, the stock plunged 7.93% following the results announcement, reflecting investor scepticism about the sustainability of this turnaround amidst mounting debt pressures and deteriorating operational efficiency. Trading at ₹228.10 with a market capitalisation of ₹2,272 crores, the Mumbai-based pharmaceutical company faces critical questions about whether this quarter represents a genuine inflection point or merely a temporary respite in an otherwise challenging trajectory.

Read full news article

Indoco Remedies Ltd Hits Intraday Low Amid Price Pressure on 28 Jul 2026

2026-07-28 13:46:51

Indoco Remedies Ltd experienced a notable decline today, touching an intraday low of Rs 234.30, reflecting significant price pressure amid a volatile trading session. The stock underperformed its sector and broader market indices, reversing gains from the previous three days.

Read full news article

Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-27 08:01:45

Indoco Remedies Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day gain of 1.87%, the stock’s broader technical landscape remains mixed, with some weekly indicators showing strength while monthly signals suggest caution. This nuanced technical picture warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Indoco Remedies Ltd is Rated Strong Sell

2026-07-25 10:10:28

Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 July 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 25 July 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Indoco Remedies Ltd Faces Technical Momentum Shift Amid Bearish Signals

2026-07-23 08:02:22

Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish stance. This development comes amid mixed technical indicator readings and a significant drop in the stock price, raising concerns for investors amid a challenging market environment.

Read full news article

View All News